APA (7th ed.) Citation

Kaye, D., Khilfeh, I., Muser, E., Morrison, L., Holiday, C., Kinkead, F., . . . George, D. (2023). RWD88 Real-World Economic Burden Pre- and Post-Progression to Metastatic Castration-Resistant Prostate Cancer (mCRPC) and after First-Line mCRPC Therapy Initiation. Value in Health, 26(6), S377. https://doi.org/10.1016/j.jval.2023.03.2117

Chicago Style (17th ed.) Citation

Kaye, D.R, I. Khilfeh, E. Muser, L. Morrison, C. Holiday, F. Kinkead, P. Lefebvre, D. Pilon, and D. George. "RWD88 Real-World Economic Burden Pre- and Post-Progression to Metastatic Castration-Resistant Prostate Cancer (mCRPC) and After First-Line MCRPC Therapy Initiation." Value in Health 26, no. 6 (2023): S377. https://doi.org/10.1016/j.jval.2023.03.2117.

MLA (9th ed.) Citation

Kaye, D.R, et al. "RWD88 Real-World Economic Burden Pre- and Post-Progression to Metastatic Castration-Resistant Prostate Cancer (mCRPC) and After First-Line MCRPC Therapy Initiation." Value in Health, vol. 26, no. 6, 2023, p. S377, https://doi.org/10.1016/j.jval.2023.03.2117.